Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection
Condition: Hiv Interventions: Drug: Raltegravir 400Mg Tab; Drug: Lamivudine 150Mg Tablet Sponsor: Guy's and St Thomas' NHS Foundation Trust Not yet recruiting - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Isentress